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Value of the data {#sec0001a}
=================

•Human Endogenous Retrovirus-K are biologically active genomic elements in many cancers and during fetal development, making evaluation in fetal malignancy especially interesting. These data support one of the first investigations of HERV-K mRNA expression in fetal tumors.•The data presented in this investigation will assist virologists and immunologists investigating HERV-K mRNA expression in human systems. It will also assist translational oncologists interested in studying the development of HERV-K as a potential neoantigen and therapeutic target for immune therapy.•These data characterize HERV-K mRNA expression in hepatoblastoma. Additional experimental validation will determine a potential role for this expression as either a tumor marker or as a immunotherapeutic target.•The data in this investigation are presented in a flexible, easy to modify format making reproducible analyses in other experimental conditions (e.g. other cancers or biological conditions) quickly feasible.

1. Data description {#sec0001}
===================

The data in this investigation relates to the expression of Human Endogenous Retrovirus-K in Hepatoblastoma. It is a companion data manuscript to the research article "Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers [@bib0001]." Human Endogenous Retroviruses are a class of genomic elements that resulted from ancient retroviral infection of the human germline. Though often transcriptionally silent, HERV\'s are biologically active in many cancers [@bib0002] as well as during fetal development [@bib0003]. We developed an approach to measure HERV-K mRNA using RNA-seq data and examined HERV-K mRNA expression in 10 Hepatoblastoma (HB) and 3 normal liver controls (NC) using a publicly available RNA-seq dataset (NCBI Biorepository: GEO accession ID GSE89). We report data on the differential gene expression of Hepatoblastomas with high and low HERV-K expression and ensuing Gene Enrichment Analysis. We also report data on RNA-seq read alignment across specific HERV-K proviruses that were found to be differentially expressed.

Supplemental File 1 represents the raw HERV-K FASTA file used to create our transcriptome alignments. Supplemental File 2 represents the full differential gene expression list (775 genes), which includes log 2-fold change and p-adjusted values following analysis and comparison of high HERV-K expressing tumors to low HERV-K expressing tumors. A Gene Enrichment analysis of the differential gene expression list was conducted using both Gene Otology (GO) terms as well as a Kyoto Encyclopedia of Genes and Genomes (KEGG). [Table 1](#tbl0001){ref-type="table"} includes the GO Molecular Function analysis. [Table 2](#tbl0002){ref-type="table"} includes the GO Cellular Localization analysis. [Table 3](#tbl0003){ref-type="table"} includes the KEGG fucntional analysis. For the HERV-K proviruses that were differentially expressed between HB and NC (1q21.3, 3q27.2, 7q22.2, 12q24.33 and 17p13.1), we plotted the read distribution of each sample across the respective provirus. [Fig. 1](#fig0001){ref-type="fig"} represents the RNA-seq read alignments from all samples across provirus 17p13.1 (panel A), 12q24.33 (panel B), 1q21.3 (panel C), 3q27.2 (panel D) and 7q22.2 (Panel E). Larger images for each individual provirus in [Fig. 1](#fig0001){ref-type="fig"} are provided in Supplemental File 3.Table 1Gene Ontology (GO) molecular function analysis following differential gene expression analysis of high HERV-K expressing Hepatoblastoma vs low HERVK expressing Hepatoblastoma.Table 1:Functional CategoryGenes in listTotal genesEnrichment False Discovery Rate (Adjusted-*p*-value)Phospholipid binding324410.021578265Collagen binding10720.023567822Lipid binding457610.023567822Identical protein binding9218710.023567822Extracellular matrix structural constituent161790.040987689Growth factor binding141500.043859833Extracellular matrix binding8560.043859833Protein kinase binding396730.046968545Table 2Gene Ontology (GO) cellular localization analysis following differential gene expression analysis of high HERV-K expressing Hepatoblastoma vs low HERVK expressing Hepatoblastoma (Top 20 terms).Table 2:Functional CategoryGenes in listTotal genesEnrichment FDRSecretory granule809469.06E−12Vesicle22542521.39E−11Secretory vesicle8711081.39E−11Extracellular region part20136932.14E−11Vesicle lumen453863.07E−11Extracellular organelle14123266.29E−11Cytoplasmic vesicle lumen443856.29E−11Extracellular exosome14023006.29E−11Extracellular vesicle14123246.29E−11Extracellular space18834791.41E−10Secretory granule lumen413676.38E−10Extracellular region22846172.16E−09Cytoplasmic vesicle part10917617.46E−09Cytoplasmic vesicle14426252.85E−08Intracellular vesicle14426282.88E−08Collagen-containing extracellular matrix384251.26E−06Platelet alpha granule lumen14701.92E−06Extracellular matrix445512.64E−06Endomembrane system22549886.27E−06Lysosome547971.78E−05Table 3Kyoto Encyclopedia of Genes and Genomes Enrichment Analysis following differential gene expression analysis of high HERV-K expressing Hepatoblastoma vs low HERVK expressing Hepatoblastoma.Table 3:Functional CategoryGenes in listTotal genesEnrichment False Discovery Rate (Adjusted *p*-value)Amoebiasis14960.000793149Complement and coagulation cascades12780.001119036Fatty acid degradation8440.005062775Legionellosis9550.005062775Peroxisome10820.012590092Focal adhesion171990.012590092Human papillomavirus infection243300.012590092PI3K-Akt signaling pathway243530.020654396Rheumatoid arthritis10890.020654396ECM-receptor interaction9820.034941883AGE-RAGE signaling pathway in diabetic complications101000.034941883Epithelial cell signaling in Helicobacter pylori infection8680.034941883Salmonella infection9850.036101621Regulation of actin cytoskeleton162140.036577774Tryptophan metabolism6420.038157306Oocyte meiosis111240.041198024IL-17 signaling pathway9920.047460432Toxoplasmosis101110.04997533Fig. 1Graphical representation of uniquely aligned reads across HERV-K provirus (A)17p13.1 (B) 12q24.33 (C) 1q21.3 (D) 3q27.2 and (E) 7q22.2 created in bioinformatics platform Geneious. The x-axis represents the genomic position along the provirus. Major annotated regions of the proviral genome at each provirus are illustrated at the bottom of the panel. Coding regions for viral proteins Gag, Pro, Pol, Env, Rec or Np9 are represented by green bars, but does not necessarily infer an open-reading frame for the protein. Individual reads from each sample are represented on the y-axis. Abbreviations: FT- fetal tumor (hepatoblastoma), NC- normal control (liver).Fig. 1:

2. Experimental design, materials, and methods {#sec0002}
==============================================

2.1. HERV-K database {#sec0003}
--------------------

Approximately 90 HERV-K proviruses have been identified to date in the human genome. However, HERV-K proviruses are currently not well annotated in human transcriptome databases. This makes quantifying HERV-K mRNA expression difficult using standard RNA-seq pipelines which rely on gene annotation for quantification. We searched the NCBI Data Repository for HERV-K proviral sequences, excluding solo long terminal repeats (LTRs). The search resulted in 91 HERV-K proviruses (GenBank ID JN675007-JN675097) [@bib0004]. Using the sequence of each provirus we created a HERV-K FASTA file. We then employed two separate analytical pipelines for RNA-seq analysis: one for HERV-K mRNA quantification and differential gene expression, and the second for proviral alignment and visualization, both are described in detail below.

2.2. Hepatoblastoma dataset (publicly available) {#sec0004}
------------------------------------------------

For the analysis in this investigation, we utilized a publicly available RNA-seq dataset of 10 hepatoblastoma samples and 3 normal liver controls. The data was generated as part of a larger investigation to identifying activated cancer pathways in hepatoblastoma aggressive hepatoblastoma [@bib0005]. The raw sequencing data are available from the NCBI biorepository (GEO accession ID GSE89775). The raw .fastq files were downloaded using the NCBI Sequence Read Archive (SRA) Toolkit. Following download, data was analyzed with the program FASTQC and was confirmed to be from strand-specific, 100 bp paired-end libraries containing approximately 40 M reads per sample (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc). Trimmomatic was used to remove illumina adaptors, low-quality reads and assure a minimum read length of 50 bp [@bib0006].

2.3. Proviral quantification and differential expression {#sec0005}
--------------------------------------------------------

We concatenated the HERV-K FASTA file onto the human cDNA transcriptome from Ensembl (GRCh38.95) (available at ftp://ftp.ensembl.org/pub/release-95/fasta/homo_sapiens/cdna/). The concatenated file allowed us to analyze HB and NC RNA-seq reads aligned to the full human transcriptome as well as HERV-K proviral loci. We used the alignment program Salmon [@bib0007] in mapping-based mode with the validateMappings flag to create a count matrix over the full human transcriptome including the concatenated HERV-K sequences (example code: salmon quant -i GRCh38_HERVK.fa -l A −1 NC_1\_1.fq −2 NC_1\_2.fq --validateMappings -o NC_1\_quant). Transcript abundance estimates from Salmon were imported into R (version 3.5.1) using tximport [@bib0008]. Gene abundance estimates were normalized for sequencing depth using DESeq2 [@bib0009]. We then focused on the read counts assigned to HERV-K loci and performed a differential gene expression analysis also using DESeq2. A p-adjusted value less than 0.05 (calculated using Benjamini-Hochberg False Discovery Rate) and an absolute value of log2 fold change greater than 1.5 were considered significant [@bib0010].

2.4. Gene enrichment analysis {#sec0006}
-----------------------------

Hepatoblastoma samples demonstrated heterogeneity in overall HERV-K expression levels and were sub-classified as high HERV-K expressing tumors and low HERV-K expressing tumors. A differential gene expression analysis between the 3 highest HERV-K expressing tumors and the 3 lowest HERV-K expressing tumors was conducted in DESeq2 as described above. A Gene Enrichment analysis of the differential gene expression list was conducted using both Gene Otology (GO) as well as a Kyoto Encyclopedia of Genes and Genomes (KEGG) terms. The analysis was performed using the clusterProfiler package in R [@bib0011]. Significantly enriched terms were determined by a False Discovery Rate \< 0.05.

2.5. Proviral alignment and visualization {#sec0007}
-----------------------------------------

We utilized the HERV-K FASTA file to create a positional index using the alignment program HISAT2 (example code: hisat2-build HB_Data/HERVK_Genome.FASTA HERVK_Genome_tran) [@bib0012]. We aligned the HB and NC samples to the HISAT2-HERV-K index to create .BAM files. Uniquely mapped reads were selected with SAMtools (MAPQ Score \>= 50). We imported the uniquely aligned .BAM files into the bioinformatics and genomic visualization platform Geneious (Biomatters, Auckland, New Zealand). For the HERV-K proviruses that were differentially expressed between HB and NC, we plotted read distribution of each sample across the respective provirus.
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